- Home
- PULM vs HYFM Comparison
PULM vs HYFM Comparison
Compare PULM & HYFM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PULM
- HYFM
- Stock Information
- Founded
- PULM 2003
- HYFM 1977
- Country
- PULM United States
- HYFM United States
- Employees
- PULM N/A
- HYFM 286
- Industry
- PULM Biotechnology: Pharmaceutical Preparations
- HYFM Industrial Machinery/Components
- Sector
- PULM Health Care
- HYFM Industrials
- Exchange
- PULM Nasdaq
- HYFM Nasdaq
- Market Cap
- PULM 28.3M
- HYFM 16.0M
- IPO Year
- PULM N/A
- HYFM 2020
- Fundamental
- Price
- PULM $8.87
- HYFM $3.57
- Analyst Decision
- PULM
- HYFM Hold
- Analyst Count
- PULM 0
- HYFM 2
- Target Price
- PULM N/A
- HYFM $7.00
- AVG Volume (30 Days)
- PULM 20.6K
- HYFM 34.1K
- Earning Date
- PULM 05-15-2025
- HYFM 05-13-2025
- Dividend Yield
- PULM N/A
- HYFM N/A
- EPS Growth
- PULM N/A
- HYFM N/A
- EPS
- PULM N/A
- HYFM N/A
- Revenue
- PULM $1,921,000.00
- HYFM $176,650,000.00
- Revenue This Year
- PULM N/A
- HYFM $5.45
- Revenue Next Year
- PULM $134.88
- HYFM $5.33
- P/E Ratio
- PULM N/A
- HYFM N/A
- Revenue Growth
- PULM N/A
- HYFM N/A
- 52 Week Low
- PULM $1.78
- HYFM $1.50
- 52 Week High
- PULM $10.40
- HYFM $8.55
- Technical
- Relative Strength Index (RSI)
- PULM 69.72
- HYFM 59.27
- Support Level
- PULM $7.94
- HYFM $3.00
- Resistance Level
- PULM $9.37
- HYFM $3.91
- Average True Range (ATR)
- PULM 0.66
- HYFM 0.31
- MACD
- PULM 0.30
- HYFM 0.01
- Stochastic Oscillator
- PULM 88.69
- HYFM 79.98
About PULM Pulmatrix Inc.
Pulmatrix Inc is a biopharmaceutical company that has focused on the development of novel inhaled therapeutic products intended to prevent and treat migraine and respiratory diseases with important unmet medical needs using its patented dry powder delivery technology, iSPERSE. Its pipeline of clinical assets includes PUR3100 for the treatment of acute migraine, PUR1800 for the treatment of acute exacerbations of chronic obstructive pulmonary disease (AECOPD), and PUR1900 for the treatment of ABPA in patients with asthma and in patients with cystic fibrosis (CF).
About HYFM Hydrofarm Holdings Group Inc.
Hydrofarm Holdings Group Inc is a distributor and manufacturer of agriculture equipment and supplies. Some of its products includes lighting solutions, growing media (i.e., premium soils and soil alternatives), nutrients, equipment, and supplies sold under proprietary, exclusive/preferred brands, or non-exclusive/distributed brands. The business is organized into two operating segments, the U.S. and Canada.